Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
saula.checquolo@uniroma1.it
Saula Checquolo
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
saula.checquolo@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Opsonin-deficient nucleoproteic corona Endows unPEGylated liposomes with stealth properties in vivo
ACS NANO
2022
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential
JOURNAL OF HEPATOLOGY
2022
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance
FRONTIERS IN ONCOLOGY
2022
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL
CANCERS
2022
Notch signaling in female cancers. A multifaceted node to overcome drug resistance
CANCER DRUG RESISTANCE
2021
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response
ONCOGENESIS
2020
Current trends in ATRA delivery for cancer therapy
PHARMACEUTICS
2020
Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation
INTERNATIONAL JOURNAL OF ONCOLOGY
2019
Notch3 targeting. A novel weapon against ovarian cancer stem cells
STEM CELLS INTERNATIONAL
2019
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL
FRONTIERS IN ONCOLOGY
2019
Notch signaling activation as a hallmark for triple-negative breast cancer subtype
JOURNAL OF ONCOLOGY
2019
Wnt, notch, and TGF-β pathways impinge on hedgehog signaling complexity: an open window on cancer
FRONTIERS IN GENETICS
2019
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance
CANCER RESEARCH
2019
Molecular basis of Notch3-Pin1 functional crosstalk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment
PATHOBIOLOGY: FROM MOLECULAR DISEASE TO CLINICAL APPLICATION
2019
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application
The XI Notch meeting
2019
Getting insights into Pin1-Notch3 functional crosstalk in ovarian cancer
NEW TECHNOLOGIES TO FIGHT CANCER
2019
PLK1 targets NOTCH1 during DNA damage and mitotic progression
THE JOURNAL OF BIOLOGICAL CHEMISTRY
2019
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response
The Biennial Congress of the Italian Association of cell biology and differentiation
2019
Notch signaling as a therapeutic target for acute lymphoblastic leukemia
EXPERT OPINION ON THERAPEUTIC TARGETS
2018
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.
Atti del ABCD - PPh.D. meeting
2018
1
2
seguente ›
ultima »
Interessi di ricerca
Progetti di Ricerca
Molecular dissection of Notch3-Pin1 cross-talk: novel approaches of targeted therapy in ovarian cancer
Molecular basis of Notch3-Pin1 functional cross-talk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment.
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma